131 related articles for article (PubMed ID: 8944331)
1. Improvement of quality control for steroid receptor measurements: analysis of distributions in more than 40000 primary breast cancers. French Study Group on Tissue and Molecular Biopathology.
Romain S; Spyratos F; Goussard J; Formento JL; Magdelénat H
Breast Cancer Res Treat; 1996; 41(2):131-9. PubMed ID: 8944331
[TBL] [Abstract][Full Text] [Related]
2. Steroid receptor distribution in 47,892 breast cancers. A collaborative study of 7 European laboratories. The EORTC Receptor Study Group.
Romain S; Lainé Bidron C; Martin PM; Magdelenat H
Eur J Cancer; 1995; 31A(3):411-7. PubMed ID: 7786610
[TBL] [Abstract][Full Text] [Related]
3. Steroid receptor measurement in breast cancers: comparison between ligand binding and enzyme-immunoassay in cytosolic and nuclear extracts.
Luqmani YA; Temmim L; Memon A; Ali MA; Parkar AH
Int J Cancer; 1997 May; 71(4):526-38. PubMed ID: 9178804
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibodies for progesterone receptor assays and polymorphism studies in breast cancer. Comparison with radioligand assays.
Goussard J; Magdelenat H; Martin PM; Lechevrel C; Roussel G
Bull Cancer; 1988; 75(8):771-82. PubMed ID: 3052654
[TBL] [Abstract][Full Text] [Related]
5. Detection of breast tumor progesterone receptor isoforms with the PR-enzyme immunoassay kit (Abbott). Effect of heat shock proteins on epitope recognition.
Goussard J; Lemoisson E; Cren H
Ann Biol Clin (Paris); 1995; 53(3):107-13. PubMed ID: 7574094
[TBL] [Abstract][Full Text] [Related]
6. Quantitation of estradiol receptors alpha and beta and progesterone receptors in human breast tumors by real-time reverse transcription-polymerase chain reaction. Correlation with protein assays.
de Cremoux P; Tran-Perennou C; Elie C; Boudou E; Barbaroux C; Poupon MF; De Rycke Y; Asselain B; Magdelénat H
Biochem Pharmacol; 2002 Aug; 64(3):507-15. PubMed ID: 12147303
[TBL] [Abstract][Full Text] [Related]
7. Quality control study of estradiol and progesterone receptor determination.
Vermousek I; Számel I
Neoplasma; 1988; 35(3):307-14. PubMed ID: 3405339
[TBL] [Abstract][Full Text] [Related]
8. Discordant results between radioligand and immunohistochemical assays for steroid receptors in breast carcinoma.
Helin H; Isola J; Helle M; Koivula T
Br J Cancer; 1990 Jul; 62(1):109-12. PubMed ID: 2202418
[TBL] [Abstract][Full Text] [Related]
9. [Determination of estradiol receptors by immunoenzyme technique and by radioligand binding in 2134 breast tumors].
Romain S; Dussert C; Martin PM
Bull Cancer; 1991; 78(4):331-40. PubMed ID: 1713518
[TBL] [Abstract][Full Text] [Related]
10. Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer.
Allegra JC; Lippman ME; Thompson EB; Simon R; Barlock A; Green L; Huff KK; Do HM; Aitken SC
Cancer Res; 1979 May; 39(5):1447-54. PubMed ID: 427788
[TBL] [Abstract][Full Text] [Related]
11. Quantitative association between HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer.
Konecny G; Pauletti G; Pegram M; Untch M; Dandekar S; Aguilar Z; Wilson C; Rong HM; Bauerfeind I; Felber M; Wang HJ; Beryt M; Seshadri R; Hepp H; Slamon DJ
J Natl Cancer Inst; 2003 Jan; 95(2):142-53. PubMed ID: 12529347
[TBL] [Abstract][Full Text] [Related]
12. [The quantitative analysis of estradiol and progesterone receptors in breast cancer for treatment selection].
Medina M; Torres R; Loustanau E; Calzada L; Chávez Azuela J; Zárate A
Ginecol Obstet Mex; 1987 Oct; 55():261-5. PubMed ID: 3154209
[No Abstract] [Full Text] [Related]
13. Prognostic value of steroid receptors after long-term follow-up of 2257 operable breast cancers.
Pichon MF; Broet P; Magdelenat H; Delarue JC; Spyratos F; Basuyau JP; Saez S; Rallet A; Courriere P; Millon R; Asselain B
Br J Cancer; 1996 Jun; 73(12):1545-51. PubMed ID: 8664127
[TBL] [Abstract][Full Text] [Related]
14. Frequency of oestrogen and progesterone receptor positivity by immunohistochemical analysis in 7016 breast carcinomas: correlation with patient age, assay sensitivity, threshold value, and mammographic screening.
Rhodes A; Jasani B; Balaton AJ; Barnes DM; Miller KD
J Clin Pathol; 2000 Sep; 53(9):688-96. PubMed ID: 11041059
[TBL] [Abstract][Full Text] [Related]
15. Estradiol and progesterone receptors in human cutaneous melanoma.
Stoica A; Hoffman M; Marta L; Voiculetz N
Neoplasma; 1991; 38(2):137-45. PubMed ID: 2041573
[TBL] [Abstract][Full Text] [Related]
16. Determination of threshold values for determining the size of the fraction of steroid hormone receptor-positive tumor cells in paraffin-embedded breast carcinomas.
Leers MP; Hoop JG; van Beers M; van Rodijnen N; Pannebakker M; Nap M
Cytometry B Clin Cytom; 2005 Mar; 64(1):43-52. PubMed ID: 15668953
[TBL] [Abstract][Full Text] [Related]
17. [Steroid hormone receptors and survival in breast cancer patients].
Ivanova OA; Tsyrlina EV; Moiseenko VM; Semiglazov VF
Vopr Onkol; 1986; 32(6):71-6. PubMed ID: 3727485
[TBL] [Abstract][Full Text] [Related]
18. Evolution of immunoreactivity of monoclonal antibodies H222 and/or D547 used in the detection of breast cancer estrogen receptors. Varying reactivity of receptor isoforms.
Cren H; Lechevrel C; Roussel G; Goussard J
J Steroid Biochem Mol Biol; 1991 Oct; 39(4A):519-27. PubMed ID: 1911441
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor receptor-negative tumors are predominantly confined to the subgroup of estradiol receptor-positive human primary breast cancers.
Koenders PG; Beex LV; Geurts-Moespot A; Heuvel JJ; Kienhuis CB; Benraad TJ
Cancer Res; 1991 Sep; 51(17):4544-8. PubMed ID: 1873798
[TBL] [Abstract][Full Text] [Related]
20. Estradiol and progesterone receptors in human breast cancer.
Mureşan Z; Voiculetz N
Neoplasma; 1985; 32(2):217-24. PubMed ID: 4000310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
